Davide Roccarina

Plain English
This study looked at how to measure liver fat using ultrasound more accurately by testing different ways to set the area being measured. Researchers found that using a movable setup to position the ultrasound probe significantly improved the accuracy of the measurements; specifically, they found a correlation of 0.80 for the best method, compared to 0.75 for the fixed method. This is important because more accurate measurements can help doctors better evaluate liver health, especially in patients with obesity. Who this helps: Patients with liver conditions, especially those who are obese.

Plain English
This study looked at how well liver stiffness measurements (LSM) and blood test results predict serious complications in patients with primary biliary cholangitis (PBC). Researchers analyzed data from 1,793 PBC patients and found that 3.3% experienced liver failure over a median of 22 months. They discovered that the latest liver stiffness measurement was a strong predictor of liver-related issues, even when blood test results were mixed, meaning that doctors can rely more on the most recent LSM for assessing patient risk. Who this helps: This benefits doctors and medical teams caring for patients with primary biliary cholangitis.

Plain English
This study looked at a procedure called under-dilated transjugular intrahepatic portosystemic shunt (U.N-TIPS) to help patients with liver cirrhosis and high blood pressure in the veins of the liver (portal hypertension) get surgery for cancers outside the liver. Out of 34 patients, 94% were able to undergo planned surgery after the procedure, with significant improvements in their vein pressure from 21 to 11 mmHg. The results are important because they show that U.N-TIPS can make it safer for these patients to receive necessary cancer treatments that would otherwise be too risky. Who this helps: This benefits patients with liver cirrhosis and cancers outside the liver, as well as the doctors treating them.

Plain English
This study looked at how the size of shunts used to treat portal hypertension affects the risk of overt hepatic encephalopathy (OHE) in patients with cirrhosis. Researchers found that 33% of patients with smaller shunts (U-TIPS) developed OHE in one year, compared to 50% of those with larger shunts (S-TIPS). The findings highlight that smaller shunt sizes significantly lower the risk of OHE while still effectively managing complications from portal hypertension. Who this helps: This benefits patients with cirrhosis undergoing treatment for portal hypertension.

Plain English
This study examined two types of treatments for portal hypertension: under-dilated shunts (U-TIPS) and standard dilated shunts (S-TIPS). Researchers found that 6% of patients with U-TIPS experienced complications compared to 14% of those with S-TIPS, suggesting U-TIPS may be safer. Additionally, factors like higher illness severity were linked to more complications after treatment. Who this helps: This benefits patients with portal hypertension and their doctors by providing safer treatment options.

Plain English
This research studied how different ultrasound methods can help diagnose issues with the spleen, particularly in patients with liver disease. It found that advanced ultrasound techniques, such as elastography and contrast-enhanced ultrasound (CEUS), improved the ability to identify splenic conditions, making it easier to distinguish between benign and harmful lesions. This is important because better detection reduces the need for invasive tests and helps manage patient care effectively. Who this helps: This helps doctors and patients with liver disease by improving diagnosis and treatment options.

Plain English
This study examined how well a procedure called TIPS (a treatment for cirrhosis) works based on how much the pressure in the liver's blood vessels decreased right after the procedure. They looked at 415 patients and found that 66% had the desired pressure reduction. However, achieving that reduction did not improve control of fluid buildup or prevent bleeding, and in some cases, it may even lead to worse outcomes for patients with certain types of cirrhosis. Who this helps: This research benefits doctors and patients with cirrhosis receiving TIPS by highlighting that achieving certain pressure targets may not be necessary for improving outcomes.

Plain English
This study looked at how different settings in an ultrasound machine can affect the accuracy of measuring liver fat, known as hepatic steatosis. Researchers tested 101 adults and found that using a depth of 4.0 cm, a size of 4.0 cm, and a confidence level of 40% gave the best results in detecting liver fat, with accuracy rates around 93% for the mildest forms of fat accumulation. The findings are important because they help develop a standard way to use ultrasounds in checking liver health, which could improve patient care. Who this helps: This helps patients with liver conditions and doctors assessing liver health.

Plain English
This study examined a patient with severe bleeding due to complications from high blood pressure in the portal vein, caused by abnormal blood vessels in the liver. The researchers found that while blocking these abnormal vessels helped with some issues, it did not stop the bleeding, so they used a procedure called TIPS to manage the situation. This approach successfully resolved the bleeding and prevented life-threatening complications. Who this helps: This helps patients with severe liver-related complications and their doctors in managing difficult cases.

Plain English
This study looked at how well contrast-enhanced ultrasound (CEUS) can identify leftover or returning tumors in patients who had kidney-sparing treatments for kidney cancer, like freezing or partially removing the kidney. Researchers analyzed data from 188 patients and found that CEUS accurately identified recurring tumors 8.8% of the time, while 91.2% showed no tumor presence, with a high agreement rate of 96.7% when compared to another imaging method, CT scans. This is important because it helps ensure that patients do not have undetected cancer after treatment, leading to better monitoring and care. Who this helps: This helps patients with kidney cancer who have had nephron-sparing surgeries.

Plain English
The study looked at how normal levels of a liver enzyme called alkaline phosphatase (ALP) affect the long-term health of patients with primary biliary cholangitis (PBC) who are being treated with a medication called ursodeoxycholic acid (UDCA). Researchers analyzed data from 1,047 patients and found that those with normal ALP levels had a better chance of avoiding serious liver problems over ten years, gaining an average of 7.6 months free of complications. Notably, younger patients (under 62) or those with more advanced liver stiffness saw even greater benefits, with a potential gain of nearly 53 months without complications. Who this helps: This research benefits patients with PBC, especially those with higher liver stiffness or who are younger.

Plain English
This study looked at the impact of a brain condition known as overt hepatic encephalopathy (OHE) on the survival of patients with severe liver disease who underwent a specific procedure called TIPS. It found that after 30 months, the mortality rate was almost the same for patients who developed OHE (9.2% experienced ongoing symptoms) and those who didn’t, with only a 0.03% difference in death rates between the two groups. This is significant because it shows that while OHE is common after TIPS, it doesn't seem to increase the risk of dying for these patients. Who this helps: This information benefits patients with cirrhosis and their doctors by reducing concerns about the risks associated with OHE after TIPS.

Plain English
This study looked at how changes in liver stiffness measurements (LSM) relate to serious health issues in patients with primary biliary cholangitis (PBC), a liver disease. The researchers followed 3,078 patients over several years and found that 59% showed an increase in liver stiffness. They discovered that an increase in LSM raised the risk of serious complications from 21.9 to over 25 per 1,000 patients annually, while a decrease in LSM lowered the risk significantly. Who this helps: This helps patients with primary biliary cholangitis and their doctors track disease progression more effectively.

Plain English
This study looked at how changes to a protein called fibrinogen, caused by oxidative stress, can increase the risk of blood clots in people who have received liver transplants. Researchers compared 40 liver transplant recipients to 40 healthy individuals and found that the transplant patients had higher levels of oxidative stress and altered fibrinogen, which could make blood clots more likely. This matters because it helps explain why liver transplant recipients face an increased risk of serious cardiovascular issues after surgery. Who this helps: This helps liver transplant patients and their doctors understand potential risks for blood clots.

Plain English
This study looked at how well different methods of measuring liver fat using ultrasound technology compared to a more precise imaging technique called MRI. Researchers found that using either the average or the median ultrasound values resulted in very accurate liver fat measurements, with scores showing nearly perfect agreement (0.99 and 0.96). Importantly, the results also showed that it didn't matter if fewer measurements were taken or if different quality measures were applied; the accuracy remained high. Who this helps: This helps doctors who need reliable ways to assess liver fat in their patients.

Plain English
This study looked at how different ultrasound machines and operators measure the amount of fat in the liver, known as liver steatosis. Researchers tested 26 people, comparing the ultrasound measurements to a more detailed MRI fat assessment. They found that while some ultrasound systems had good agreement with MRI results, the overall consistency between different ultrasound machines was low (with a correlation rate peaking at 0.86), highlighting that results from one machine may not be trusted with results from another. Who this helps: This benefits doctors and patients by improving the understanding of liver health monitoring techniques.

Plain English
This study looked at how body composition affects the survival rates of patients with liver disease while considering the differences between men and women. It found that 41% of men had low muscle mass (sarcopenia), compared to only 27% of women. In men, low muscle mass and poor nutritional status significantly increased the risk of death, while in women, fat levels were more related to mortality, not muscle mass. Who this helps: This research benefits patients with cirrhosis, especially those being considered for liver transplants, by highlighting the different health risks for men and women.

Plain English
This study looked at the risks of death in older adults (70 years and older) with liver scarring (cirrhosis) who get a special procedure called TIPS to manage fluid buildup and bleeding. Researchers tracked 411 patients who had the procedure and found that certain factors, like kidney function (measured by creatinine levels) and sodium levels, are good indicators of who is at higher risk of dying after surgery. They concluded that while older patients do face greater mortality risks, TIPS can still be a valuable option for them, and knowing their kidney and sodium levels can help doctors make better decisions. Who this helps: This information helps doctors making treatment decisions for older patients with cirrhosis.

Plain English
This study looked at how a treatment called Transjugular Intrahepatic Portosystemic Shunt (TIPS) affects gut bacteria in patients with cirrhosis. Researchers found that after patients received TIPS, there was a 48% reduction in pressure related to liver circulation and a shift in gut bacteria that included increased beneficial bacteria and decreased ones linked to infections. Moreover, harmful inflammatory substances in the gut were reduced, which may improve overall health. Who this helps: This helps cirrhotic patients by potentially improving their gut health and reducing complications.

Plain English
This study looked at how well a new ultrasound technique called ElastPQ can measure stiffness in the liver and spleen of patients with primary sclerosing cholangitis (PSC). The researchers found that ElastPQ accurately assessed liver stiffness and was able to effectively predict liver fibrosis stages and the presence of dangerous blood vessels in the esophagus, with scores showing very high accuracy (up to 99% for advanced fibrosis). This is important because early and accurate detection of liver issues can lead to better monitoring and treatment for patients, helping prevent serious complications. Who this helps: Patients with primary sclerosing cholangitis.

Plain English
This paper discusses shear wave elastography (SWE), a technique used in medical imaging to assess the stiffness of tissues in the liver, breast, thyroid, and salivary glands. It outlines how to perform the procedure correctly, what normal stiffness values look like, and common mistakes to avoid during the examination. Understanding SWE is important because it helps doctors make better diagnoses and monitor conditions related to tissue stiffness. Who this helps: This benefits patients, doctors, and healthcare providers involved in diagnosing conditions related to these organs.

Plain English
This study focuses on how to use a medical imaging technique called shear wave elastography (SWE) to examine various organs like the pancreas, spleen, and kidney. The authors discuss the best ways to perform the technique, including potential issues that may arise and how to avoid them. This is important because better imaging can lead to more accurate diagnoses and better treatment plans for patients with conditions affecting these organs. Who this helps: Patients with organ-related health issues.

Plain English
This study looked at how the amount of collagen in the liver can help predict survival outcomes for patients with alcoholic hepatitis (AH). Researchers examined 140 patients and found that while about 48% of them died over an average of 66 months, the collagen levels didn't help predict deaths within the first 90 days. However, the amount of collagen did indicate long-term survival chances for those who survived beyond the initial 90 days, meaning that monitoring liver collagen could help identify patients at higher risk of dying later on. Who this helps: This information is beneficial for doctors treating patients with alcoholic hepatitis.

Plain English
This study looked at how well a procedure called transjugular portosystemic shunt (TIPS) helps patients with portal hypertension caused by myelofibrosis and improves their nutrition. Out of six patients followed for about 33 months, none developed liver failure or had a recurrence of dangerous bleeding, and the amount of diuretics they needed was nearly cut in half. This is important because it shows TIPS is a safe and effective way to treat these patients and improve their overall nutritional health. Who this helps: This benefits patients suffering from portal hypertension related to myelofibrosis.

Plain English
This study compared two methods, ElastPQ and FibroScan, to measure liver stiffness in patients with non-alcoholic fatty liver disease (NAFLD) to help determine the extent of liver damage (fibrosis). Researchers analyzed data from 671 patients and found that ElastPQ closely matched FibroScan in accuracy, especially for earlier stages of fibrosis, with a correlation score of 0.80. The findings are significant as they indicate that ElastPQ may be a reliable and potentially easier method for doctors to assess liver fibrosis, which is important for managing NAFLD. Who this helps: This benefits patients with non-alcoholic fatty liver disease and their doctors.

Plain English
This study looked at how measuring liver stiffness using a specific test can help predict the health outcomes of patients with primary biliary cholangitis (PBC). Researchers analyzed data from nearly 4,000 patients and found that higher liver stiffness measurements were linked to worse outcomes, such as liver complications or death, with an increase of just 1 kPa in stiffness correlating to a 4% higher risk of these issues. This is important because it means that liver stiffness measurements can help doctors better assess the risk for patients and might be used to speed up new treatments for PBC. Who this helps: This helps patients with primary biliary cholangitis and their doctors.

Plain English
This study looked at how non-alcoholic fatty liver disease (NAFLD) and high blood pressure (hypertension or HT) together affect heart and blood vessel health. Researchers found that people with both NAFLD and HT had a much higher rate of atherosclerosis (hardening of the arteries) compared to those with just NAFLD or just HT; specifically, 43% of those with both conditions had significant plaques in their arteries, compared to only about 11% for those with NAFLD alone and 22% for those with hypertension alone. This matters because it highlights that having both conditions greatly increases the risk of serious heart problems, indicating that doctors need to pay special attention to patients who have both NAFLD and HT. Who this helps: Patients with non-alcoholic fatty liver disease and high blood pressure.

Plain English
This research paper focuses on using a method called elastography to assess liver disease, specifically the stiffness of the liver, which can indicate the severity of liver fibrosis without needing a biopsy. The study found that measuring liver stiffness can help predict complications and the risk of death in patients with chronic liver disease. A specific score combining liver stiffness measurements with platelet counts showed very effective results in reducing unnecessary procedures, helping to identify those at risk for severe liver issues. Who this helps: This benefits patients with chronic liver disease and their doctors by providing safer and more accurate ways to assess liver health.

Plain English
This study looked at a new method called ElastPQ for measuring liver stiffness in patients with chronic liver disease, comparing the reliability of taking 10, 5, and 3 measurements. It found that using 5 measurements works well enough for accurate results, and that results improve significantly when a quality measure is applied (with a specific value range). This is important because it makes the testing process simpler and could lead to better diagnosis and treatment for patients with liver conditions. Who this helps: Patients with chronic liver diseases.

Plain English
This study looked at different treatments to prevent further bleeding in adults who have previously experienced bleeding from esophageal varices due to severe liver disease (cirrhosis). The analysis found that about 22.5% of patients who received sclerotherapy, a common treatment, died during follow-up, and while variceal band ligation may have fewer serious side effects, none of the treatments showed a clear advantage over the others. This matters because finding the most effective and safest options for these patients could greatly improve their quality of life and survival rates. Who this helps: Patients with liver cirrhosis and history of variceal bleeding.

Plain English
This study looked at different treatments that can prevent bleeding from enlarged veins in the esophagus (called varices) in people with liver cirrhosis. Researchers analyzed data from 66 clinical trials involving over 6,600 participants and found that treatments like beta-blockers, variceal band ligation, and sclerotherapy can lower the risk of death compared to not treating the condition (21.2% mortality for beta-blockers). However, some treatments also had higher risks of serious side effects, making it important for doctors to carefully consider the options available. Who this helps: This helps patients with liver cirrhosis and doctors deciding on preventive treatments.

Plain English
This study explored how certain blood markers can help assess the severity of non-alcoholic fatty liver disease (NAFLD), which can lead to serious health issues. Researchers examined 105 adults with NAFLD and found that higher levels of a marker called Interleukin-6 (IL-6) and lower levels of Matrix Metalloproteinase-9 (MMP-9) were linked to more severe liver damage. The study created a new scoring system (NIFI) that accurately predicts severe liver fibrosis with an 89% accuracy rate, reducing the need for invasive procedures like liver biopsies for low-risk patients. Who this helps: This helps patients with NAFLD by providing a less invasive way to assess liver damage.

Plain English
This study investigated how the size of multiple spontaneous portosystemic shunts (SPSS) affects the health outcomes of patients with liver cirrhosis. It found that patients with larger total areas of these shunts (more than 83 mm) were at a higher risk for developing severe complications like hepatic encephalopathy and had lower survival rates, with only 64% surviving after one year compared to 77% for those with smaller shunt areas. Understanding this relationship helps doctors better predict which patients are at greater risk and could lead to improved management strategies. Who this helps: This helps doctors treating patients with liver cirrhosis.

Plain English
This study looked at different treatments for ascites, a condition where fluid builds up in the abdomen due to severe liver problems, specifically in adults with advanced liver cirrhosis. It found that about 36.8% of patients receiving the standard treatment of paracentesis plus fluid replacement died within 11 months, and while some methods like the transjugular intrahepatic portosystemic shunt and adding aldosterone antagonists were linked to better outcomes for fluid resolution, they also came with higher risks of complications. This research is important because it highlights the uncertainty surrounding the best treatment options for a serious condition that many people with liver disease face. Who this helps: This helps patients with liver cirrhosis and their doctors in making informed treatment choices.

Plain English
This study looked at the long-term effects of giving a medication called ursodeoxycholic acid (UDCA) to patients after they received a liver transplant for a condition called primary biliary cholangitis (PBC). Researchers followed 780 patients and found that those who took UDCA had a 59% lower risk of PBC recurrence, a 67% lower risk of losing their transplanted liver, and a 31% lower risk of dying from any cause compared to those who did not take UDCA. This matters because it shows that preventive treatment with UDCA can significantly improve survival and health for patients who have undergone liver transplants due to PBC. Who this helps: This helps patients who have undergone liver transplantation for primary biliary cholangitis, as well as their doctors.

Plain English
In this study, researchers looked at 107 patients with autoimmune hepatitis to see how certain factors, like serum immunoglobulin G (IgG) levels, affect chances of survival without needing a liver transplant. They found that patients who normalized their IgG levels had a 95% chance of surviving without a transplant after five years, compared to 86% for those who did not normalize their levels. This shows that managing IgG levels is important for improving long-term outcomes in these patients. Who this helps: This helps patients with autoimmune hepatitis and their doctors.

Plain English
Researchers studied how hepatitis C can affect heart function and structure in patients with mild to moderate liver damage. They found that patients had noticeable changes in their heart shape and function, especially in the left ventricle and right heart sections, compared to healthy individuals. After treating the hepatitis C with direct-acting antivirals (DAAs), the patients showed improvements in heart function and reduced inflammation markers, indicating that eliminating the virus may help reverse some cardiac issues. Who this helps: This benefits hepatitis C patients, particularly those with heart concerns.

Plain English
This study looked at how measuring collagen in liver biopsies can predict health outcomes for patients with alcohol-related liver disease (ALD). Researchers found that higher collagen levels were linked to a greater risk of liver failure and death: for every increase in collagen, the risk of liver-related death grew by 4% and the risk of liver failure increased by 8% in patients without advanced cirrhosis. This matters because it provides a new tool for doctors to assess the severity of ALD and potentially improve patient care. Who this helps: This helps patients with alcohol-related liver disease and their doctors.

Plain English
This study looked at the effects of sarcopenia, which is a loss of muscle mass, in patients with liver disease who had a procedure called TIPSS to treat severe fluid buildup in the abdomen. Researchers followed 107 patients for about 14 months and found that 57% had sarcopenia, but this condition did not increase the risk of complications or death during that time. In fact, patients showed improvement in muscle mass after the procedure, indicating that having sarcopenia should not prevent patients from receiving this treatment. Who this helps: This benefits patients with liver disease who are considering TIPSS, as well as their doctors in treatment decision-making.

Plain English
This study looked at how well the spleen functions in patients with certain autoimmune gastrointestinal disorders, specifically autoimmune atrophic gastritis (AAG), autoimmune enteropathy (AIE), and autoimmune liver disease (AILD). The researchers found that out of 40 AAG patients, 55% had poor spleen function; for AIE, it was 67%; and for AILD, it was 88%. The findings indicate that people with these conditions are more likely to have spleen problems, which increases their risk of severe bacterial infections, emphasizing the need for vaccinations to protect them. Who this helps: This helps patients with autoimmune gastrointestinal disorders.

Plain English
This study looked at factors that lead to the return of primary biliary cholangitis (PBC) in patients after they have received a liver transplant. Researchers found that 22% of patients had a recurrence of PBC within 5 years, and this jumped to 36% after 10 years. Key factors that increased the risk included being younger than 50 at diagnosis and using a specific medication called tacrolimus, while using cyclosporine reduced the risk. Notably, when PBC returned, it significantly increased the chances of losing the transplanted liver and dying. Who this helps: This research benefits patients with PBC and healthcare providers, improving understanding of treatment options and risks after liver transplantation.

Plain English
This study focused on patients with liver diseases known as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) to see if certain guidelines could predict the presence of dangerous varices—enlarged veins that can bleed and require treatment—without needing invasive procedures. The researchers found that using the Baveno-VI criteria achieved a 0% rate of missed cases needing treatment in both PBC and PSC, allowing about 30-40% of patients to skip unnecessary endoscopies. This is important because it can reduce the need for invasive procedures, making care easier and safer for patients. Who this helps: Patients with primary biliary cholangitis and primary sclerosing cholangitis.

Plain English
This study looked at cholangiocarcinoma (CCA), a type of liver cancer, and its relationship with primary sclerosing cholangitis (PSC), a liver disease. Researchers found that patients with both PSC and CCA had significantly higher scores on a liver fibrosis test compared to those with only PSC; specifically, the score was much higher in CCA patients with or without PSC. This matters because it highlights that the enhanced liver fibrosis score could help identify patients at risk for CCA, which may improve early diagnosis and treatment. Who this helps: Patients with PSC and their doctors.

Plain English
This study looked at liver diseases in HIV-positive patients who might have a condition called nonalcoholic fatty liver disease (NAFLD). Out of 97 patients, 28% were found to have NAFLD, and 20% had significant fibrosis, which is scarring of the liver. The researchers also tested non-invasive methods to assess liver damage, finding that the FIB4 test effectively excluded advanced fibrosis with a 95% negative predictive value. Who this helps: This helps patients with HIV and their doctors by providing better tools for assessing liver health without needing more invasive procedures.

Plain English
This study examined how effective different antibiotics are for treating spontaneous bacterial peritonitis (SBP) in patients with severe liver disease, known as decompensated liver cirrhosis. The research included 12 trials with a total of 1,278 patients, and found that about 75% of patients recovered from SBP, while 25% died within three months. However, there was no clear evidence that any specific antibiotic was more effective than others, highlighting a need for better-designed studies on this issue. Who this helps: This helps patients with spontaneous bacterial peritonitis and their doctors in choosing treatment options.

Plain English
This study looked at the presence of spontaneous portosystemic shunts (SPSS) in nearly 1,730 patients with cirrhosis, finding that 60% of them had such shunts. Larger shunts were linked to more severe liver health issues, with patients showing higher rates of complications like hepatic encephalopathy (HE) – 48% in those with large shunts compared to 20% without. This is important because it highlights that having SPSS can lead to more severe health problems and increase the risk of death or needing a liver transplant, making it crucial for doctors to monitor these shunts in cirrhosis patients. Who this helps: This helps patients with cirrhosis and their doctors by identifying risks associated with liver disease.